Bevacizumab and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Bevacizumab and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bevacizumab
Brand name: Avastin, Mvasi
Synonyms: n.a.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bevacizumab-Insulin degludec Subcutaneous
- Bevacizumab-Insulin detemir
- Bevacizumab-Insulin Detemir (Cartridges and Prefilled Syringes)
- Bevacizumab-Insulin Detemir (Vials)
- Bevacizumab-Insulin detemir Subcutaneous
- Bevacizumab-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Bevacizumab Injection
- Insulin degludec and liraglutide Subcutaneous-Bevacizumab Intravenous
- Insulin degludec and liraglutide Subcutaneous-Bevacizumab-awwb
- Insulin degludec and liraglutide Subcutaneous-Bevacizumab-awwb Intravenous
- Insulin degludec and liraglutide Subcutaneous-Bevespi Aerosphere
- Insulin degludec and liraglutide Subcutaneous-Bevyxxa